Plus Therapeutics (PSTV) Misses Q4 EPS by 424c

Plus Therapeutics (NASDAQ: PSTV) reported Q4 EPS of ($4.24). Revenue for the quarter came in at $4.91 million.

For earnings history and earnings-related data on Plus Therapeutics (PSTV) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Corpay agrees to $100M FTC settlement over marketing practices
• Arrive AI and DXC Technology partner to bring delivery tech to factories